Maheen Mausoof Adamson, PhD
Dr. Maheen Mausoof Adamson is Senior Scientific Clinical Research Director at the Headache Center for Excellence in Rehabilitation Service, at the VA Palo Alto Health Care System and Clinical Associate Professor (Affiliated) in Neurosurgery at Stanford University School of Medicine.
As the Principal Investigator of the Adamson Lab, Dr. Adamson is striving to decipher the underlying factors associated with Traumatic Brain Injury (TBI), Alzheimer’s disease, pain, depression, Post-Traumatic Stress Disorder (PTSD), and cognitive aging.
For patients with complex physical, neurological, and psychiatric health histories an accurate diagnosis is a critical first step in their recovery journey. As a global leader in neuroimaging, including magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI), neuromodulation, and related biomarkers, Dr. Adamson is using her expertise to translate innovative diagnostic tools and treatments into clinical care. In addition, by partnering with various academic institutions, VHA and DOD the Adamson lab is developing and testing the efficacy of innovative treatments such as repetitive transcranial magnetic stimulation, virtual reality and, very recently, low-intensity focused ultrasound.
The Adamson lab has a strong commitment to bench to bedside translational research and rehabilitation. Dr. Adamson is a passionate advocate for health equality, accessibility to care, and minority groups where she continuously presents epidemiological research on gender differences in TBI to policy leaders.
The Adamson Lab is involved in a range of studies including TBI and more:
- Assessing the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) in TBI population.
- Comparing standard-of-care physical therapy with virtual reality to enhance the biofeedback-driven healing mechanisms for the treatment of pain.
- Treatment of chronic pain and depression with rTMS in veterans with Gulf War illness.
- Tracking and identifying factors underlying the chronic health complaints characteristics of brain injury and highlight gender/sex and other health disparities in symptom reporting.
- Investigating the efficacy of Low-Intensity Focused Ultrasound (LIFU) with meditation to treat TBI-related headaches
- Understanding the long-term neurological impact of COVID-19 on neurocognitive and psychiatric disorders.
- Applying machine learning and artificial intelligence technology to neuroimaging and other biomarker data to further enhance diagnosis of TBI with respect to social determinants of health
For additional information, to participate in research, or to support our research contact Srija Seenivasan on 469-600-6554 or email firstname.lastname@example.org.